Has Jasmin Dao received payments from drug or device companies?

Yes. Drug and device makers reported $482,350 in general payments to Jasmin Dao across 494 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jasmin Dao did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jasmin Dao come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jasmin Dao

Pediatrics · Long Beach, CANPI 1164811568

Payments from drug & device makers

$482,350in general payments, 2019–2025

Across 494 payments — averaging $976.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$314K
Pfizer$136K
Biohaven Pharmaceutical Holding Company Ltd.$21K
Sarepta Therapeutics, Inc.$3K
UCB, Inc.$2K
AbbVie$1K
plus $5K from 44 others

$21,934in research payments, 2019–2025

Across 11 payments — averaging $1994.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$18K
Eli Lilly$4K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	24	$313,862
Pfizer	52	$136,275
Biohaven Pharmaceutical Holding Company Ltd.	7	$20,632
Sarepta Therapeutics, Inc.	9	$2,579
UCB, Inc.	91	$2,222
AbbVie(2 entities)	69	$1,491
Lundbeck LLC	17	$469
Corium, LLC	16	$437
Aquestive Therapeutics, Inc.	22	$416
CSL Behring	14	$377
Supernus Pharmaceuticals, Inc.	7	$340
SK Life Science, Inc.	13	$326
Neurelis, Inc.	15	$307
Lilly USA, LLC	13	$295
Biogen	13	$281
Jazz Pharmaceuticals Inc.	9	$243
Greenwich Biosciences, Inc.	5	$132
Biohaven Pharmaceuticals, Inc.	7	$119
Tris Pharma Inc	7	$117
Upsher-smith Laboratories LLC	5	$101
Ironshore Pharmaceuticals Inc.	4	$91
Impel Pharmaceuticals Inc.	4	$85
Teva Pharmaceuticals USA, Inc.	4	$83
Zogenix Inc.	4	$75
Vertical Pharmaceuticals, LLC	3	$67
Neurocrine Biosciences, Inc.	2	$67
Travere Therapeutics, Inc.	21	$65
Aucta Pharmaceuticals, Inc.	4	$64
Takeda Pharmaceuticals U.S.A., Inc.	3	$61
Livanova USA, Inc.	3	$55
Mallinckrodt Enterprises LLC	2	$49
Noven Therapeutics, LLC	2	$49
Eisai Inc.	2	$49
Genentech USA, Inc.	2	$45
Collegium Pharmaceutical, Inc.	2	$42
Biomarin Pharmaceutical Inc.	2	$36
Vanda Pharmaceuticals Inc.	1	$34
Axsome Therapeutics, Inc.	1	$33
Catalyst Pharmaceuticals, Inc.	1	$30
Acadia Pharmaceuticals Inc	1	$29
Mallinckrodt Hospital Products Inc.	1	$28
Assertio Therapeutics, Inc.	2	$27
Intrabio Inc	1	$26
Johnson & Johnson	1	$25
Sanofi	1	$24
Scilex Pharmaceuticals Inc.	1	$21
Sunovion Pharmaceuticals Inc.	1	$19
Azurity Pharmaceuticals, Inc.	1	$18
AstraZeneca	1	$17
Neos Therapeutics, LP	1	$16

How this compares

$482,350 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California →

Other pediatrics in Long Beach

Nicola KleinOakland$81.9M
Lawrence SherRolling Hills Estates$38.4M
Carey ChronisVentura$6.3M
Jose DiazDowney$5.4M
Bruce BuckinghamSan Jose$3.1M
Patrick WalshAnaheim$3M
Teresita Salazar-GuadizBellflower$2.7M
Liberation de LeonParamount$2.7M
Melvin HeymanSan Francisco$2.5M
Aftab NazMadera$2.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →